Is my portfolio
One Report to Answer all your Questions!
Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1669.20
-31.35 (-1.84%) USFDA conducts GMP inspection of Sun Pharma’s Halol facility
Date: 14-06-2025US Food and Drug Administration (USFDA) has conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries’ Halol facility (Gujarat, India) from June 2, 2025 to June 13, 2025. At the conclusion of the inspection, the USFDA issued a Form-483, with 8 observations.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.